Floatz logo

Finasteride

Androgenetic Alopecia

HairDx, LLCSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Androgenetic Alopecia cohort.

Asset / SponsorPhaseRating
Proxalutamide
Applied Biology, Inc.
N/AD
cb-03-10
Cosmo Technologies Ltd
Early Phase 1NR

Same molecule, other indications

Finasteride is also rated in:

Prostatic HyperplasiaDormant
BB
Indicative ·
65 / 100
View asset →
prostate cancerDormant
BB
Indicative ·
64 / 100
View asset →
prostate intraepithelial neoplasiaDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →